Benitec Biopharma Inc (BNTC)

SG&A Expense Growth

-10.16%

Quarterly · Period ending:

BNTC logo

BNTC SG&A Expense Growth

Latest reported-10.16%
BNTC Quarterly SG&A Growth (QoQ) (0.00% → -10.16%)
High-resolution chart · PNG

BNTC sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Benitec Biopharma Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-10.1593%
-3.4336%
17.2548%
-52.281%
52.5%
63.0996%
145.6936%
8.3497%
29.0241%
-13.4868%
17.6015%
13.1291%
11.645%
-34.0848%
-2.9688%
23.6317%
16.1556%
-21.9953%
-16.0627%
32.9427%
49.2711%
-51.2553%
14.9156%
-3.2139%
-10.4431%
-21.2308%
141.5728%
-9.4533%
-20.8372%
27.7485%
-49.9062%
132.356%
-16.5386%
-0.8658%
-6.3683%
5.6078%
-12.1313%
15.595%
-1.7829%
6.4078%
-30.29%
-25.9591%
75.0481%
-48.4148%
46.097%
-3.0144%
-4.7505%
46.6535%
0.1713%
31.7249%
-9.8054%
25.3021%
-0.7037%
-0.2304%
0.8904%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.